SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 3.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 48.4. According to RSI analysis, sunpharma is technically weak. 1.0 SUNPHARMA RSI Chart
MACD (?) MACD: -1.88 and Signal Line: -3.28. According to MACD analysis, sunpharma is marginally strong. 7.0 SUNPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sunpharma is facing resistance at 524 and support level is at 511.0775. 6.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 20-day exponential moving average which is a negative signal. According to exponential moving average analysis, sunpharma is in a strong downtrend. Major resistance levels are 513.151, 522.4807, 548.8612. 1.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.567. 5.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 523.8015 and 533.625. Support level is 492.0. 2.5 SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 11.6 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 9.48 which means SUNPHARMA is in a trading range and there is no trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 26, 2018
Open Price 514.0
High Price 522.7
Low Price 511.3
Close Price 512.6
Absolute Change -1.45
Percentage Change -0.282%
Weekly Change 0.668%
Monthly Change 1.48%
Yearly Change -20.3%
52-week high 656.95
52-week low 432.7
Corporate Actions
ExDate Purpose
September 18, 2017 AGM/DIV-RS 3.50 PER SHARE
September 08, 2016 AGM/DIV-RE 1/- PER SHARE
July 14, 2016 BUY BACK
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.612
Confidence in Beta1.97%
Market Capital Rs. 123368.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 8.9
TTM Price-to-Earnings (P/E) Ratio 57.6
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 26 April 2018: Deliverable Quantity:1.62e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 26 April 2018: Daily Volatility:0.2713 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 26 April 2018: PCR_OI:0.334 PCR:0.307 NA SUNPHARMA PCR Chart
Option Pain (?) 26 April 2018: Max Pain:520.0 NA SUNPHARMA Option Pain Chart
Premium (?) 26 April 2018 Premium: -0.35 Futures OI:3358300.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 26 April 2018: Price:512.6 Put with maximum OI:500.0 Call with maximum OI:520.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
April 26, 2018 512.25 3358300.0 9874.0 16004.0 512.6
May 31, 2018 515.5 56732500.0 10484.0 16889.0 512.6
June 28, 2018 518.05 128700.0 70.0 73.0 512.6

Announcements

April 26, 2018 SShareholders meetingSun Pharmaceutical Industries Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on Jun 01, 2018
April 19, 2018 SUpdatesSun Pharmaceutical Industries Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 29, 2018 February 14, 2018 TResultsTo consider and take on record, the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017.
October 30, 2017 November 14, 2017 tResultsto consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017.
See all Board Meetings

SUNPHARMA is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 497 Rs. 504.1 Rs. 508.4 Rs. 515.5 Rs. 519.8 Rs. 526.9 Rs. 531.2